Atlas Trials

Investigating Mechanistic Predictors of Interpatient Variability and Temozolomide (TMZ) Induced Haematological Toxicity for Glioma Patients

Clinical trial NCT06546631 · RECRUITING

Trial details

NCT number
NCT06546631
Sponsor
University College Cork
Status
RECRUITING
Study type
OBSERVATIONAL
Glioma
Start date
2024-08-22
Primary completion
2027-07-01
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.